DSM-IV used broader substance-induced mood disorder terminology. DSM-5 separated bipolar-related and depressive presentations when the larger mood-disorders grouping was divided. The APA explains that DSM-5-TR then clarified wording so the bipolar-related category would not be misunderstood as requiring depression or as allowing depression alone to establish it.
The revision also made clearer that medication-related symptoms can arise during use or in a withdrawal context. ICD-11 uses substance-specific mood-disorder categories with symptom qualifiers rather than precisely the same organizational structure. Historical labels therefore should not be converted mechanically.
These changes reflect an effort to distinguish the nature of the mood disturbance and its likely cause, while avoiding an automatic lifelong bipolar label after any unusual reaction to a medicine.